Novavax headquarters in Gaithersburg, MD (Nathan Howard/Bloomberg via Getty Images)

No­vavax plans to have up­dat­ed Covid vac­cine to mar­ket by Sep­tem­ber — but will it be ready in time?

No­vavax is prepar­ing to have its XBB.1.5 Covid-19 vac­cine ready for mar­ket by the end of Sep­tem­ber, call­ing it its “high­est pri­or­i­ty.” How­ev­er, the com­pa­ny is still in the mid­dle of the fil­ing process with the FDA.

The com­pa­ny said Tues­day in its sec­ond-quar­ter earn­ings re­port that it plans to have its up­dat­ed Covid vac­cine ready for the fall vac­ci­na­tion sea­son.

“We sub­mit­ted the pre­clin­i­cal and clin­i­cal pack­ages, and we’re go­ing to com­plete that file this month,” No­vavax R&D chief Fil­ip Dubovsky said on an in­vestor call.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Senior Associate

Alexandria Real Estate Equities

Durham, NC, USA